XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Israel Ltd | 198,888 | $471,000 | 0.14% |
| Noked Capital LTD | 198,888 | $471,000 | 0.14% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 49,271 | $102,000 | 0.00% |
| UBS Group AG | 812 | $2,000 | 0.00% |